An underground market for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Drug Acquiring Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to message these profiles privately for source information, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.
Some professionals said the demand for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.
Service Reaction and Material Removal
According to TikTok, the platform has removed problematic material and banned associated hashtags and query recommendations. The company said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of weight loss, positive testimonials and detailed guides for mixing or injecting at home.
Within moments of entering one community, a seller posted contact information, where the majority of purchases occur. The seller sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about body mass, medical conditions or previous experience.
Item Details and Pricing
Inside these communities, messages display dark colored packages with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.
Service Moderation and Security Actions
A spokesperson for Telegram said it actively monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they can’t verify. Even if the research behind this drug is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to possibly serious health risks”.
